is not a video entry

Small-scale farming account for a large part of the farming industry in low and middle-income countries. Despite small-scale livestock producers’ key role in the agricultural industry, existing market barriers and constraints hinder their opportunities to access high-quality animal health products and services.

Different market barriers are present across the entire value chain and deter animal health companies from investing in these markets. Some of the major barriers identified are lack of reliable market information and market entry, proper distribution mechanisms of products, scattered demand, or service provision.

As part of GALVmed’s Strategy2030, we are proposing a dedicated focus on collaborating with different partners and veterinary authorities to develop tailored technology platforms to bridge the gaps and overcome these market barriers. This suggested platform approach marks a significant change in GALVmed commercial development strategy. Whereas previously, a single commercial partner would spearhead a single initiative, the new approach will enable the entire industry to plug into a benefit from a single platform. By collectively addressing the key constraints facing the entire animal health value chain, the proposed platforms have the potential to deliver a comprehensive, financially sustainable solution that will unlock new opportunities for growth in the animal health industry.

With this proposed approach, the end goal is to significantly increase investment in the small-scale sector by the animal health industry, and improve market supply and adoption of key animal health products that will grant better opportunities to small-scale producers to protect their livestock and secure their livelihoods.

This blog was written as part of the campaign “Barriers to Animal Health Markets”